Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion type Assertion NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_head.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion evidence source_evidence_literature NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion SIO_000772 20868306 NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion wasDerivedFrom befree-2016 NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion wasGeneratedBy ECO_0000203 NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.